We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Genetic Factors Increase Cancer Risk from H pylori

By Biotechdaily staff writers
Posted on 04 Dec 2002
A recent study based on the fact that both Helicobacter pylori genotype and host genetic polymorphisms play a role in determining the consequences of H pylori infection has shown that certain combinations of bacterial and host genotypes are particularly associated with the occurrence of gastric carcinoma. More...
The study appeared in the November 20, 2002, issue of the Journal of the National Cancer Institute.

Investigators from the Institute of Molecular Pathology and Immunology at the University of Porto (Portugal) employed a polymerase chain reaction (PCR) line probe assay to determine genotypic variations in virulence-associated genes of H pylori vacA (s and m regions) and cagA in 221 subjects with chronic gastritis and 222 patients with gastric carcinoma.

Certain combinations of bacterial and host genotypes were found to be strongly associated with the risk of stomach cancer. For example, people carrying a high-activity version of interleukin-1 beta gene who were infected by an H pylori strain with a particular variant of the vacA vacuolating cytotoxin had a nearly 90-fold increase in the risk of stomach cancer.

The authors concluded, "Our findings indicate that H pylori and host genotyping can be important in better defining disease risk and preferentially targeting H pylori eradication to high-risk individuals.”




Related Links:
Institute of Molecular Pathology and Immunology

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Pipette Calibration System
Artel PCS®
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.